METASTATIC ADENOID CYSTIC CARCINOMA
Clinical trials for METASTATIC ADENOID CYSTIC CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC ADENOID CYSTIC CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC ADENOID CYSTIC CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug targets rare Cancer's genetic weakness
Disease control Recruiting nowThis study tests a new drug called REM-422 in people with advanced adenoid cystic carcinoma (ACC), a rare cancer of the glands. The drug works by breaking down a specific genetic message (MYB) that helps the cancer grow. The goal is to see if the drug is safe and can shrink tumor…
Matched conditions: METASTATIC ADENOID CYSTIC CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Remix Therapeutics • Aim: Disease control
Last updated May 17, 2026 04:44 UTC
-
Can targeted radiation slow a rare cancer? new trial aims to find out
Disease control Recruiting nowThis study tests whether giving a precise, high-dose radiation treatment (SBRT) early can slow the growth of adenoid cystic carcinoma that has spread to a few spots in the body. About 32 adults with 1 to 5 metastatic lesions will receive SBRT to all visible tumors. Researchers wi…
Matched conditions: METASTATIC ADENOID CYSTIC CARCINOMA
Phase: NA • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated May 01, 2026 16:01 UTC